Violent crime and substance abuse: A medico-legal comparison between deceased users of anabolic androgenic steroids and abusers of illicit drugs

2007 ◽  
Vol 173 (1) ◽  
pp. 57-63 ◽  
Author(s):  
Fia Klötz ◽  
Anna Petersson ◽  
Dag Isacson ◽  
Ingemar Thiblin
Author(s):  
Iiro Jokipalo ◽  
Anna Khudayarov

AbstractDoping-untested strength-sport athletes (powerlifters, strongmen, armlifters, etc.,) are infamous for their doping use, but their exact doping regimens are not known. The purpose of this study was to provide a reasonable portrait of doping history in this specific athlete group for medical practitioners. Seventy-five athletes were selected by netnography of the social media community around the Finnish doping-untested strength-sport federations on the basis of their activity in doping-related discussions, and the athletes were invited to answer a detailed doping-related anonymous survey. Fifty respondents completed the survey. 100% of the respondents reported use of anabolic androgenic steroids, 66% reported use of stimulants, and 80% use of non-steroidal anabolic substances. The doses of both testosterone products and human growth hormone were notably larger than reported in previous studies of gym users (mostly non-competitive athletes). The subjects reported simultaneous use of an average 5.66 illegal substances, and lifetime use of 16.78 illegal substances. The doses of illicit drugs, as well as polypharmacy, among competitive doping-untested strength-sport athletes are higher than previously reported among recreational gym users, and side effects are likely in this specific population.


Author(s):  
Maria Christou ◽  
Panagiota Christou ◽  
Georgios Markozannes ◽  
Agathocles Tsatsoulis ◽  
George Mastorakos ◽  
...  

1996 ◽  
Vol 42 (7) ◽  
pp. 1001-1020 ◽  
Author(s):  
W Schänzer

Abstract Anabolic androgenic steroids (AAS) are misused to a high extent in sports by athletes to improve their physical performance. Sports federations consider the use of these drugs in sports as doping. The misuse of AAS is controlled by detection of the parent AAS (when excreted into urine) and (or) their metabolites in urine of athletes. I present a review of the metabolism of AAS. Testosterone is the principal androgenic steroid and its metabolism is compared with that of AAS. The review is divided into two parts: the general metabolism of AAS, which is separated into phase I and phase II metabolism and includes a systematic discussion of metabolic changes in the steroid molecule according to the regions (A-D rings), and the specific metabolism of AAS, which presents the metabolism of 26 AAS in humans.


2017 ◽  
Vol 24 (9) ◽  
pp. 1210-1220 ◽  
Author(s):  
Marc Harris ◽  
Michael Dunn ◽  
Tina Alwyn

An estimated 293,000 people living in the United Kingdom have used anabolic-androgenic steroids. However, there is currently no intervention to reduce usage available in practice or academic circulation throughout the United Kingdom. This study aimed to test a novel hypothesis that increased levels of intrasexual competition may play an important influential role in the use of anabolic-androgenic steroids. Significantly higher levels of intrasexual competition were evident in users compared to non-users but only in the novice group (0–2 years of experience). The research provides evidence for intrasexual competition potentially influencing anabolic-androgenic steroid use but only during the initial stages of usage.


1990 ◽  
Vol 9 (6) ◽  
pp. 774-791 ◽  
Author(s):  
W. Jack Rejeski ◽  
Edward Gregg ◽  
Jay R. Kaplan ◽  
Stephen B. Manuck

Sign in / Sign up

Export Citation Format

Share Document